Author: Jonathan Smith
Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here! Out of the office, I travel, play video games and board games, drink beer and play the piano.
Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis
FDA Greenlights First Treatment for Rare Autoimmune Eye Disease
Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
How Biotech Startups Can Have a Stronger Position When Scaling Up
Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants
International Collaboration on Brink of Resurrecting Northern White Rhinos
This Biotech Is Developing a Pill to Rival Antibiotics in Vaginal Infections
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
